Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Open-label Study Using ex Vivo Injection of ICG to Detect SLN in Patients With Colon Cancer

NCT01995591 is registered in ClinicalTrials.gov with Jules Bordet Institute as lead sponsor.

NCT NCT01995591
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01995591 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Open-label Study Using ex Vivo Injection of ICG to Detect SLN in Patients With Colon Cancer
Lead sponsor
Jules Bordet Institute
Phase
Observational
Overall status
Completed
Start date
January 31, 2013
Completion date
February 28, 2015
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

colon cancer, colon surgery